In males, MECP2 loss of function was long thought to be lethal or uniformly severe, and affected boys remain under-recognised. Their clinical range is still poorly defined. We assembled a multicentre Turkish series of 22 hemizygous male probands ascertained through routine diagnostic testing rather than severe-phenotyp...
Çağrı Doğan, Mehmet Burak Mutlu, A. Cansu et al.· BMC Pediatrics· 0 citations
Highlights What are the main findings? In inhaled corticosteroid/long-acting β-agonist-treated children and adolescents with asthma, blood eosinophil percentage and symptom-based control (ACQ score) were independently associated with FeNO in a multivariable model adjusted for prespecified baseline covariates (age, sex,...
Azer Kılıç Başkan, B. Oztosun, D. Ozceker et al.· Children· 0 citations
Recurrent non-CF-causing variants should be reviewed case by case; the present data alone do not justify pathogenic reclassification, and phase-resolved and functional studies are required.
M. Alay, Filiz Özdemir, Deniz Ağırbaşlı et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.